Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exact Sciences Corp (NASDAQ:EXAS)

33.32
Delayed Data
As of May 26
 +0.13 / +0.39%
Today’s Change
5.81
Today|||52-Week Range
36.14
+149.40%
Year-to-Date

Today’s Trading

Previous close33.19
Today’s open33.05
Day’s range32.82 - 33.59
Volume1,368,072
Average volume (3 months)2,935,491
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+4.68%
Earnings growth (this year)+17.30%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+151.99%
P/E ratioNM
Price/Sales13.76
Price/Book10.91

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.10-1.38%
ADAPAdaptimmune Therapeu...+0.02+0.38%
NKTRNektar Therapeutics-0.71-3.30%
XONIntrexon Corp-0.22-1.00%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$99.4M
Annual profit (last year)-$167.2M
Net profit margin-168.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts